Rhenman & Partners Asset Management Ab Boston Scientific Corp Transaction History
Rhenman & Partners Asset Management Ab
- $1.2 Billion
- Q3 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Boston Scientific Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 590,000 shares of BSX stock, worth $60.6 Million. This represents 4.12% of its overall portfolio holdings.
Number of Shares
590,000
Previous 595,000
0.84%
Holding current value
$60.6 Million
Previous $45.8 Million
7.9%
% of portfolio
4.12%
Previous 4.53%
Shares
27 transactions
Others Institutions Holding BSX
# of Institutions
1,572Shares Held
1.18BCall Options Held
6.82MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$13.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.45 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.89 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$3.37 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...